Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 166 (5-6), 353-67

Update in Antifungal Therapy of Dermatophytosis

Affiliations
Review

Update in Antifungal Therapy of Dermatophytosis

Aditya K Gupta et al. Mycopathologia.

Abstract

Treatment of dermatophyte infection involves primarily oral and/or topical formulations of azoles or allylamines, particularly itraconazole and terbinafine. Topical medications applied once or twice daily are the primary treatment indicated for tinea corporis/cruris, and tinea pedis/manuum. Use of oral antifungals may be practical where the tinea involvement is extensive or chronic, or where application of a topical is not feasible. For tinea unguium (onychomycosis) and tinea capitis, oral therapies are the primary treatments provided. Recently, topical amorolfine and ciclopirox formulations have been approved for use in milder onychomycosis cases, and their role in the treatment of the different clinical forms of onychomycosis is currently being defined. Relapse of infection remains a problem, particularly with tinea pedis/unguium. Appropriate follow-up duration and education of patients on proper foot hygiene are also important components in providing effective therapy.

Similar articles

See all similar articles

Cited by 47 PubMed Central articles

See all "Cited by" articles

References

    1. Br J Dermatol. 2000 May;142(5):965-8 - PubMed
    1. J Am Acad Dermatol. 1997 Dec;37(6):969-74 - PubMed
    1. Dermatol Clin. 2003 Jul;21(3):537-42 - PubMed
    1. Clin Drug Investig. 1996 Aug;12(2):59-66 - PubMed
    1. Dermatol Clin. 2003 Jul;21(3):507-9, vii - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback